Premedication Prior to Dental Appointment After Total Knee Replacement
Antibiotic prophylaxis is NOT recommended for routine dental procedures in patients with total knee replacements, and antiplatelet/anticoagulant medications should be continued during dental appointments 1, 2.
Antibiotic Prophylaxis: Not Indicated
The evidence strongly supports discontinuing routine antibiotic prophylaxis for dental procedures in total knee arthroplasty patients:
The 2015 ADA guideline explicitly states: "In general, for patients with prosthetic joint implants, antibiotic prophylaxis is not recommended to prevent prosthetic joint infection; prophylactic antibiotic should not be given" 1. This reversed the 2009 AAOS recommendation and represents the current standard of care.
The 2013 joint ADA/AAOS statement recommended "discontinuing the long-standing practice of routinely prescribing antibiotic prophylaxis for patients with prosthetic joint implants" 1.
Recent high-quality research confirms this approach: A 2025 meta-analysis of 157,466 patients found no significant reduction in periprosthetic joint infection rates with antibiotic prophylaxis (PJI incidence 0.07-0.3%), and actually showed a slight nonsignificant increase in risk among those receiving antibiotics 3.
A 2023 matched cohort study of nearly 2 million TKA patients found statistically similar rates of PJI and revision between those receiving antibiotic prophylaxis before invasive dental procedures and those who did not (OR 0.62,95% CI 0.11-4.00) 4.
Rare Exceptions to Consider
While routine prophylaxis is not indicated, individual patient factors may warrant consideration in truly high-risk scenarios:
- Active immunosuppression (not just inflammatory arthropathies)
- HIV infection with low CD4 counts
- Active malignancy on chemotherapy
- Previous prosthetic joint infection
- Severe malnutrition
Even in these cases, the evidence does not strongly support prophylaxis, but shared decision-making with the patient and orthopedic surgeon may be appropriate 1.
Anticoagulant/Antiplatelet Management: Continue Medications
For patients on antiplatelet or anticoagulant therapy, continue these medications through dental procedures 2:
Antiplatelet Agents (Aspirin, Clopidogrel, etc.)
Continue ASA or P2Y12 inhibitors during minor dental procedures rather than stopping them 2.
For patients on dual antiplatelet therapy (ASA + P2Y12 inhibitor): Continue ASA and may interrupt the P2Y12 inhibitor if needed 2.
Evidence from small randomized trials and cohort studies shows no increase in major bleeding with ASA continuation during dental procedures 2.
Warfarin/Vitamin K Antagonists
Continue warfarin for minimal-to-moderate bleeding risk dental procedures 2.
Most routine dental cleanings, simple extractions, and restorative work fall into this category.
Direct Oral Anticoagulants (DOACs)
While not explicitly addressed in the provided guidelines for dental procedures specifically, the general principle of continuing anticoagulation for minor procedures applies.
Coordinate with the prescribing physician if concerns exist about high bleeding risk procedures.
Common Pitfalls to Avoid
Do not reflexively prescribe antibiotics based on outdated 1997-2003 guidelines that many patients and dentists still reference.
Do not stop antiplatelet agents "to be safe" - the thromboembolic risk outweighs bleeding risk for routine dental work.
Do not confuse cardiac prophylaxis guidelines with joint prophylaxis - patients may have prosthetic heart valves requiring prophylaxis, but this is separate from joint replacement considerations.
Maintain good oral hygiene - this is more important than prophylactic antibiotics for preventing infections 1.